Comera Life Sciences (CMRAW) Competitors $0.0001 0.00 (-87.50%) (As of 10:04 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends CMRAW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, AMPE, ARAV, ACABW, and ACABUShould you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Ampio Pharmaceuticals (AMPE), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Atlantic Coastal Acquisition Corp. II (ACABU). These companies are all part of the "pharmaceutical products" industry. Comera Life Sciences vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Ampio Pharmaceuticals Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II 180 Life Sciences (NASDAQ:ATNFW) and Comera Life Sciences (NASDAQ:CMRAW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Does the MarketBeat Community favor ATNFW or CMRAW? 180 Life Sciences and Comera Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AComera Life SciencesN/AN/A Which has better earnings & valuation, ATNFW or CMRAW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AComera Life Sciences$1.00MN/AN/AN/AN/A Is ATNFW or CMRAW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Comera Life Sciences N/A N/A N/A Does the media prefer ATNFW or CMRAW? In the previous week, 180 Life Sciences' average media sentiment score of 1.87 beat Comera Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Comera Life Sciences Neutral Summary180 Life Sciences and Comera Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Ad Darwin2024 Election Year Stocks: Uncover Hidden Gems!In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. Get Comera Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMRAW vs. The Competition Export to ExcelMetricComera Life SciencesBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$178.25M$4.99B$8.82BDividend YieldN/A3.54%7.68%4.07%P/E RatioN/A188.0283.1114.50Price / SalesN/A17,250.131,397.6888.61Price / CashN/A11.4633.1632.45Price / BookN/A7.334.644.65Net IncomeN/A-$19.20M$117.31M$224.84M7 Day PerformanceN/A7.16%-3.01%-1.01%1 Month PerformanceN/A9.28%-4.13%-0.24%1 Year PerformanceN/A29.08%30.13%24.88% Comera Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMRAWComera Life SciencesN/A$0.00-87.5%N/A+14.3%$0.00$1.00M0.002Gap DownHigh Trading VolumeATNFW180 Life SciencesN/A$0.01flatN/A-25.0%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04flatN/A-2.6%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03flatN/AN/A$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$3.11+0.3%N/A+112.0%$0.00$306.77M0.004Short Interest ↓Positive NewsHigh Trading VolumeALVOAlvotech2.9236 of 5 stars$11.73-2.8%N/A+34.4%$0.00$93.38M-6.341,026Gap UpAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$0.00N/A0.0020High Trading VolumeARAVAravive0.7191 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06flatN/A+26.3%$0.00N/A0.004Positive NewsHigh Trading VolumeACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/A-23.6%$0.00N/A0.004Gap Down Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ALVO Alternatives AMPE Alternatives ARAV Alternatives ACABW Alternatives ACABU Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CMRAW) was last updated on 11/19/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Comera Life Sciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Comera Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
